Heike Allgayer

9.2k citations
131 papers · 7.3k indexed · 1 hit paper · h-index 44
    • Protease and Inhibitor Mechanisms 34
    • MicroRNA in disease regulation 27
    • Cancer-related molecular mechanisms research 18
    • RNA modifications and cancer 14
    • Ubiquitin and proteasome pathways 13
    • Circular RNAs in diseases 10
  • Oncology top 1%
    • Peptidase Inhibition and Analysis 28
    • Cancer Cells and Metastasis 9
  • Immunology top 5%

Heike Allgayer

130 papers receiving 7.2k citations

Hit Papers

MicroRNA-21 (miR-21) post-transcriptionally downregulates...1.6k200720262013201950010001.5k

Peers

Heike Allgayer
Comparison fields: 5 of 127
  • Cancer Research 4.0k
  • Molecular Biology 4.9k
  • Oncology 1.9k
  • Immunology and Allergy 265
  • Immunology 702
Replace Carter Van Waes with:
Carter Van Waes United States
Shiv Srivastava United States
Dominic T. Moore United States
Hongchuan Jin China
Hasan Körkaya United States
Xiujuan Qu China
Ranju Ralhan India
Muh‐Hwa Yang Taiwan
Ai‐Wu Ke China
Fengzhi Li United States
Heike Allgayer relative to Carter Van Waes United States Carter Van Waes's profile →
Citations per field
00.5×1.5×
Carter Van Waes · 1×
Citations per year

Countries citing papers authored by Heike Allgayer

Since Specialization
Citations

This map shows the geographic impact of Heike Allgayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heike Allgayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heike Allgayer more than expected).

Fields of papers citing papers by Heike Allgayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heike Allgayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heike Allgayer. The network helps show where Heike Allgayer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Heike Allgayer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Heike Allgayer Line = papers co-authored together Heike Allgayer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 20218
3 202016
4 201550
5 201561
6 201419
7 201344
8 201330
9 201211
10 201114
11 2010256
12 2010103
13 200923
14 2009104
15 20091
16 200730
17 200745
18 20067
19 199945
20 199735

About Heike Allgayer

Heike Allgayer is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 131 papers that have together received 7.3k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (34 papers), Peptidase Inhibition and Analysis (28 papers), MicroRNA in disease regulation (27 papers), Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (14 papers), Ubiquitin and proteasome pathways (13 papers), Circular RNAs in diseases (10 papers) and Cancer Cells and Metastasis (9 papers). The work is most often cited by research in Cancer Research (4.0k citations), Molecular Biology (4.9k citations) and Oncology (1.9k citations). Heike Allgayer has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Irfan A. Asangani, Giridhar Mudduluru, Jöerg H. Leupold, Stefan Post, Nancy H. Colburn, Suhail Ahmed Kabeer Rasheed, Dessislava A. Nikolova, M. M. Heiss, Regalla Kumarswamy and Mohammed Abba. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026